Protagenic Therapeutics, Inc.\new Amortization of Debt Issuance Costs and Discounts
Protagenic Therapeutics, Inc.\new (PTIX) reported Amortization of Debt Issuance Costs and Discounts of $648.00 thousand for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2011-11-14
- Protagenic Therapeutics, Inc.\new amortization of debt issuance costs and discounts for the quarter ending 2011-09-30 was -$520.00K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month |
|---|---|---|---|
| 2011-09-30 | -$520.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $648.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.17M 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |